الإحصائيات الأساسية
| LEI | 549300IWQPQMJGDOVC54 |
| CIK | 1399708 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Neovasc Inc
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| April 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15F CERTIFICATION OF A FOREIGN PRIVATE ISSUER’S TERMINATION OF REGISTRATION OF A CLASS OF SECURITIES UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ITS TERMINATION OF THE DUTY TO FILE REPORTS UNDER SECTION 13(a) OR SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36458 NEOVAS |
|
| April 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2023 Commission File Number: 001-36458 NEOVASC INC. (Translation of registrant’s name in English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of prin |
|
| April 12, 2023 |
Exhibit 99.1 Notice of Change in Corporate Structure Pursuant to Section 4.9 of National Instrument 51-102 “Continuous Disclosure Obligations” Item 1 Names of the Parties to the Transaction Neovasc Inc. (“Neovasc”) Shockwave Medical, Inc. (“Shockwave”) Item 2 Description of the Transaction On April 11, 2023, Shockwave completed its acquisition of Neovasc by way of a statutory plan of arrangement ( |
|
| April 12, 2023 |
Exhibit 99.2 Form 51-102F3 Material Change Report Pursuant to Section 7.1 of National Instrument 51-102 “Continuous Disclosure Obligations” Item 1 Name and Address of Company Neovasc Inc. (“Neovasc”) 2135 – 13700 Mayfield Place Richmond, BC V6V 2E4 Item 2 Date of Material Change April 11, 2023. Item 3 News Release On April 11, 2023, a news release relating to the material change referred to herein |
|
| April 11, 2023 |
Exhibit 99.2 1- Name of the applicant corporation(s) Corporation number 5 - Name of the other bodies corporate involved, if applicable Corporation number or jurisdiction 2 - Name of the corporation(s) the articles of which are amended, if applicable Corporation number 3 - Name of the corporation(s) created by amalgamation, if applicable Corporation number 4 - Name of the dissolved corporation(s), |
|
| April 11, 2023 |
April 11, 2023 VIA EDGAR Securities and Exchange Commission (the “Commission”) 100 F Street, N. |
|
| April 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2023 Commission File Number: 001-36458 NEOVASC INC. (Translation of registrant’s name in English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of prin |
|
| April 11, 2023 |
As filed with the Securities and Exchange Commission on April 11, 2023 As filed with the Securities and Exchange Commission on April 11, 2023 Registration No. |
|
| April 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pr |
|
| April 11, 2023 |
As filed with the Securities and Exchange Commission on April 11, 2023 As filed with the Securities and Exchange Commission on April 11, 2023 Registration No. |
|
| April 11, 2023 |
As filed with the Securities and Exchange Commission on April 11, 2023 As filed with the Securities and Exchange Commission on April 11, 2023 Registration No. |
|
| April 11, 2023 |
Exhibit 99.1 |
|
| April 11, 2023 |
SHOCKWAVE MEDICAL COMPLETES ACQUISITION OF NEOVASC SHOCKWAVE MEDICAL COMPLETES ACQUISITION OF NEOVASC SANTA CLARA, CALIF. - April 11, 2023 - Shockwave Medical, Inc. (NASDAQ: SWAV) ("Shockwave"), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the completion of its previously announced acquisition of Neovasc Inc. ("Neovasc"). The Neovasc Reducer System (the "Reducer |
|
| March 31, 2023 |
See Accompanying Notes to the Consolidated Financial Statements Exhibit 99.2 Neovasc Inc. CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2022, 2021 and 2020 (Expressed in U.S. dollars) CONTENTS Page Report of Independent Registered Public Accounting Firm (PCAOB ID Number 248) 1 – 2 Report of Independent Registered Public Accounting Firm (PCAOB ID Number 1390) 3 – 4 Consolidated Statements of Financial Position 5 Consolidated Statements of L |
|
| March 31, 2023 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 99.4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our report dated March 31, 2023, with respect to the consolidated financial statements of Neovasc Inc. for the year ended December 31, 2022, included in the Current Report on Form 6-K. We consent to the incorporation by reference of said report in the Registration Statements of Neovasc Inc. on Form F-10 (File No. |
|
| March 31, 2023 |
Exhibit 99.3 Neovasc Inc. Management’s Discussion and Analysis FOR THE YEARS ENDED DECEMBER 31, 2022, 2021 and 2020 (Expressed in U.S. Dollars) Q4 2022 MANAGEMENT’S DISCUSSION AND ANALYSIS This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) covers the audited consolidated financial statements of Neovasc Inc. (the “Company”, “Neovasc”, “we”, “us”, or |
|
| March 31, 2023 |
NEOVASC INC. ANNUAL INFORMATION FORM FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 March 31, 2023 Exhibit 99.1 NEOVASC INC. ANNUAL INFORMATION FORM FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 March 31, 2023 1 TABLE OF CONTENTS GLOSSARY 2 TERMS OF REFERENCE 3 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND RISK FACTORS 4 CORPORATE STRUCTURE 8 Intercorporate Relationships 9 GENERAL DEVELOPMENT AND DESCRIPTION OF THE BUSINESS 9 Three Year History 11 Neovasc’s Products 15 Specialized Skil |
|
| March 31, 2023 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 99.5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our report dated March 9, 2022, with respect to the consolidated financial statements of Neovasc Inc. for the years ended December 31, 2021 and December 31, 2020, included in the Current Report on Form 6-K. We consent to the incorporation by reference of said report in the Registration Statements of Neovasc Inc. o |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2023 Commission File Number: 001-36458 NEOVASC INC. (Translation of registrant’s name in English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of prin |
|
| March 9, 2023 |
Exhibit 99.1 SUPREME COURT OF BRITISH COLUMBIA VANCOUVER REGIS TRY MAR 0 9 2023 THE SUPREME COURT OF BRITISH COLUMBIA No. 5230798 Vancouver Registry - IN THE MATTER OF SECTION 192 OF THE CANADA BUSINESS CORPORATIONS ACT, R.S.C. 1985, C. 44, AS AMENDED AND I N THE MATTER OF A PROPOSED ARRANGEMENT INVOLVING NEOVASC INC. AND SHOCKWAVE MEDICAL, INC. NEOVASC INC. PETITIONER ORDER MADE AFTER APPLICATION |
|
| March 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2023 Commission File Number: 001-36458 NEOVASC INC. (Translation of registrant’s name in English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of prin |
|
| March 7, 2023 |
Exhibit 99.2 Special Meeting of Shareholders of Neovasc Inc. (the “Company”) March 6, 2023 REPORT OF VOTING RESULTS Pursuant to Section 11.3 of National Instrument 51-102 This report sets out the matter voted upon and the results of the votes conducted at the special meeting (the “Meeting”) of holders of common shares (the “Shares”) of the Company held on March 6, 2023. The total number of Shares |
|
| March 7, 2023 |
Neovasc Shareholders Approve Acquisition by Shockwave Medical Exhibit 99.1 Neovasc Shareholders Approve Acquisition by Shockwave Medical VANCOUVER, BC – March 6, 2023 – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as defined below) have approved the previously-announced acquisition of all of t |
|
| March 7, 2023 |
6-K 1 tm238538d16k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2023 Commission File Number: 001-36458 NEOVASC INC. (Translation of registrant’s name in English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, |
|
| February 10, 2023 |
Exhibit 99.3 Security Class Holder Account Number Form of Proxy - Special Meeting to be held on March 6, 2023 This Form of Proxy is solicited by and on behalf of Management. Notes to proxy 1. Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend and act on their behalf at the meeting or any adjournment or postponement thereof. If yo |
|
| February 10, 2023 |
Exhibit 99.6 |
|
| February 10, 2023 |
Exhibit 99.7 Date: February 10, 2023 RE: Meeting of the shareholders of Neovasc Inc. to be held on March 6, 2023 (the “Meeting”) I, Chris Clark, the Chief Financial Officer of Neovasc Inc. hereby certify that: (a) arrangements have been made to have proxy related materials for the Meeting sent in compliance with National Instrument 54-101 (the “Instrument”), to all beneficial owners at least 21 da |
|
| February 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2023 Commission File Number: 001-36458 NEOVASC INC. (Translation of registrant’s name in English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of p |
|
| February 10, 2023 |
LETTER OF TRANSMITTAL FOR REGISTERED HOLDERS OF COMMON SHARES NEOVASC INC. Exhibit 99.4 The management Information Circular and Instructions accompanying this Letter of Transmittal should be read carefully before this Letter of Transmittal is completed. THE DEPOSITARY OR YOUR BROKER OR OTHER FINANCIAL ADVISOR WILL ASSIST YOU IN COMPLETING THIS LETTER OF TRANSMITTAL. IT IS IMPORTANT THAT YOU VALIDLY COMPLETE, DULY EXECUTE AND RETURN THIS LETTER OF TRANSMITTAL IN ACCORDANC |
|
| February 10, 2023 |
Exhibit 99.5 |
|
| February 10, 2023 |
Exhibit 99.2 These materials are important and require your immediate attention. They require shareholders of Neovasc Inc. to make important decisions. If you are in doubt as to how to make such decisions, please contact your financial, legal, tax or other professional advisors. If you are a holder of Shares and have any questions or require more information with regard to voting your Shares, plea |
|
| February 10, 2023 |
Exhibit 99.1 NEOVASC INC. Suite 5138 – 13562 Maycrest Way Richmond, British Columbia Canada V6V 2J7 Telephone No.: (604) 270-4344 – Fax No.: (604) 270-4384 NOTICE OF SPECIAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that a special meeting (the “Meeting”) of the holders of common shares (“Shares”) of the Corporation (the “Shareholders”) of Neovasc Inc. (“Neovasc” or the “Corporation”) will be |
|
| February 1, 2023 |
Neovasc Announces German Reimbursement Renewal Neovasc Announces German Reimbursement Renewal VANCOUVER and MINNEAPOLIS Neovasc, Inc. |
|
| February 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| January 27, 2023 |
Exhibit 99.1 Date: January 27, 2023 510 Burrard St, 3rd Floor Vancouver BC, V6C 3B9 www.computershare.com To: All Canadian Securities Regulatory Authorities Subject: Neovasc Inc. Dear Sir/Madam: We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: Meeting Type : Special Meeting Record Date for Notice of Meeting : February 03, 2023 Record Date |
|
| January 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| January 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the Month of January 2023 Commission File Number: 001-36458 NEOVASC INC. (Translation of registrant’s name in English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pr |
|
| January 18, 2023 |
FORM 51-102F3 MATERIAL CHANGE REPORT Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company Neovasc Inc. (“Neovasc”, the “Company”, “we” or “our”) 13562 Maycrest Way, Suite 5138 Richmond, BC V6V 2J7 Item 2: Date of Material Change January 17, 2023 Item 3: News Release A news release announcing the material change was issued on January 17, 2023 through Newsfile Corp. and a copy was subsequently filed on |
|
| January 17, 2023 |
EX-99.1 2 tm233662d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Execution Version SHOCKWAVE MEDICAL, INC. as Purchaser and NEOVASC INC. as Corporation ARRANGEMENT AGREEMENT JANUARY 16, 2023 TABLE OF CONTENTS Article 1 INTERPRETATION 1 Section 1.1 Defined Terms 1 Section 1.2 Certain Rules of Interpretation 21 Section 1.3 Schedules 22 Article 2 THE ARRANGEMENT 23 Section 2.1 Arrangement 23 Section 2.2 Inte |
|
| January 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| January 17, 2023 |
FORM OF SUPPORT AND VOTING AGREEMENT EX-99.2 3 tm233662d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 FORM OF SUPPORT AND VOTING AGREEMENT THIS AGREEMENT is made as of January [], 2023. BETWEEN: [●] ("Shareholder") - and - SHOCKWAVE MEDICAL, INC., a corporation existing under the laws of the State of Delaware ("Purchaser") WHEREAS Shareholder is the beneficial owner of [[●] common shares, [●] options to acquire common shares and [●] restrict |
|
| January 17, 2023 |
6-K 1 tm233662d16k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the Month of January 2023 Commission File Number: 001-36458 NEOVASC INC. (Translation of registrant’s name in English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia |
|
| January 17, 2023 |
FORM OF Conversion, Support and voting AGREEMENT EX-99.3 4 tm233662d1ex99-3.htm EXHIBIT 99.3 Exhibit 99.3 FORM OF Conversion, Support and voting AGREEMENT THIS AGREEMENT is made as of January [], 2023. BETWEEN: STRUL MEDICAL GROUP LLC ("SMG") - and - SHOCKWAVE MEDICAL, INC., a corporation existing under the laws of the State of Delaware ("Purchaser") - and - NEOVASC INC., a corporation existing under the Canada Business Corporations Act (“Corpor |
|
| January 17, 2023 |
Shockwave Medical to Acquire Neovasc Shockwave Medical to Acquire Neovasc VANCOUVER, BC via NewMediaWire - Neovasc Inc. |
|
| November 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| November 28, 2022 |
Neovasc Announces Progress on COSIRA-II Clinical Trial Neovasc Announces Progress on COSIRA-II Clinical Trial VANCOUVER and MINNEAPOLIS Neovasc Inc. |
|
| November 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| November 18, 2022 |
Neovasc Comments on European Heart Journal Publication EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Comments on European Heart Journal Publication VANCOUVER and MINNEAPOLIS Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that European Heart Journal - Case Reports has published an article titled, "Implantation of the Coronary Sinus Reducer for Refractory Angina due to Coronary Microvascular Dysfunction in the Context of |
|
| November 10, 2022 |
Neovasc Announces Third Quarter Financial Results and Provides Corporate Update Neovasc Announces Third Quarter Financial Results and Provides Corporate Update VANCOUVER and MINNEAPOLIS - (NewMediaWire) - Nov 10, 2022 - Neovasc Inc. |
|
| November 10, 2022 |
Neovasc Inc. Management?s Discussion and Analysis FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021 (Expressed in U.S. Dollars) Q3 2022 MANAGEMENT'S DISCUSSION AND ANALYSIS This Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") covers the unaudited condensed interim consolidated financial statements of Neovasc Inc. (the "Company", "Neovasc |
|
| November 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| November 10, 2022 |
Form 52-109F2 Certification of Interim Filings Full Certificate EX-99.3 4 exhibit99-3.htm EXHIBIT 99.3 Form 52-109F2 Certification of Interim Filings Full Certificate I, Fred Colen, the President and Chief Executive Officer of Neovasc Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Neovasc Inc. (the "issuer") for the interim period ended September 30, 2022. 2. No misrepr |
|
| November 10, 2022 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Chris Clark, the Chief Financial Officer of Neovasc Inc. |
|
| November 10, 2022 |
See Accompanying Notes to the Unaudited Condensed Interim Consolidated Financial Statements EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Inc. UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021 (Expressed in U.S. dollars) CONTENTS Page Unaudited Condensed Interim Consolidated Statements of Financial Position 1 Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss 2 Unaudited Condensed |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| November 8, 2022 |
Neovasc Reducer Obtains U.S. Outpatient Reimbursement Neovasc Reducer Obtains U.S. Outpatient Reimbursement VANCOUVER and MINNEAPOLIS via NewMediaWire - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the Centers for Medicare and Medicaid Services ("CMS") has assigned the Neovasc Reducer™ ("Reducer") implant procedure a new outpatient reimbursement code payment status indicator, enabling U.S. hospitals to be reimbur |
|
| October 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| October 27, 2022 |
Neovasc to Report Third Quarter Financial Results on November 10, 2022 Neovasc to Report Third Quarter Financial Results on November 10, 2022 VANCOUVER and MINNEAPOLIS via NewMediaWire - Neovasc Inc. |
|
| September 20, 2022 |
Neovasc Provides Update on Mitral Valve Program EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Provides Corporate Update Following Clinical Data Release New Data Presented on the Neovasc Reducer™ in Patients With Microvascular Disease VANCOUVER and MINNEAPOLIS Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced positive clinical data at the Transcatheter Cardiovascular Therapeutics Conference ("TCT") held September 16-19 in |
|
| September 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address o |
|
| September 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address o |
|
| September 16, 2022 |
Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit VANCOUVER and MINNEAPOLIS via NewMediaWire - Neovasc, Inc. |
|
| September 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address o |
|
| September 15, 2022 |
Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina VANCOUVER and MINNEAPOLIS Neovasc Inc. |
|
| September 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address o |
|
| September 8, 2022 |
Neovasc Announces Key Events at TCT 2022 Neovasc Announces Key Events at TCT 2022 VANCOUVER and MINNEAPOLIS Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced its participation and presence at the Transcatheter Cardiovascular Therapeutics TCT 2022 conference ("TCT"), hosted by the Cardiovascular Research Foundation ("CRF"), taking place in person at the Boston Convention & Exhibition Center, September 16-19, 20 |
|
| August 30, 2022 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Can |
|
| August 30, 2022 |
Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - August 30, 2022 - Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the H.C. Wainwright 24th Annual Global Investment Conference to be held September 12-14, 2022, in New York City. Neovasc's P |
|
| August 11, 2022 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Fred Colen, the President and Chief Executive Officer of Neovasc Inc. |
|
| August 11, 2022 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Chris Clark, the Chief Financial Officer of Neovasc Inc. |
|
| August 11, 2022 |
Neovasc Inc. Management?s Discussion and Analysis FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022 AND 2021 (Expressed in U.S. Dollars) Q2 2022 MANAGEMENT'S DISCUSSION AND ANALYSIS This Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") covers the unaudited condensed interim consolidated financial statements of Neovasc Inc. (the "Company", "Neovasc", "we |
|
| August 11, 2022 |
See Accompanying Notes to the Unaudited Condensed Interim Consolidated Financial Statements Neovasc Inc. UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022 AND 2021 (Expressed in U.S. dollars) CONTENTS Page Unaudited Condensed Interim Consolidated Statements of Financial Position 1 Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss 2 Unaudited Condensed Interim Consolidated Statements of Changes i |
|
| August 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of p |
|
| August 11, 2022 |
Neovasc Announces Second Quarter Financial Results and Provides Corporate Update Neovasc Announces Second Quarter Financial Results and Provides Corporate Update VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - Aug 11, 2022 - Neovasc Inc. |
|
| July 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pri |
|
| July 28, 2022 |
Neovasc to Report Second Quarter Financial Results on August 11, 2022 Neovasc to Report Second Quarter Financial Results on August 11, 2022 VANCOUVER and MINNEAPOLIS Neovasc Inc. |
|
| July 26, 2022 |
Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations VANCOUVER and MINNEAPOLIS Neovasc, Inc. |
|
| July 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pri |
|
| July 5, 2022 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canad |
|
| July 5, 2022 |
Neovasc Announces Direct Sales Operations in United Kingdom Expansion Driven by NICE Guidelines and Enhanced Reimbursement for the Neovasc Reducer? VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc, Inc. |
|
| June 8, 2022 |
Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference VANCOUVER and MINNEAPOLIS via NewMediaWire - Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the 2022 Sidoti & Co. Summer Small Cap Virtual Investor Conference to be held June 15-16, 2022. Neovasc's Chief Operating Officer, Bill Little, |
|
| June 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pri |
|
| May 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of prin |
|
| May 24, 2022 |
Neovasc to Participate in H.C. Wainwright Global Investment Conference Neovasc to Participate in H.C. Wainwright Global Investment Conference VANCOUVER and MINNEAPOLIS via NewMediaWire - Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the H.C. Wainwright Global Investment Conference to be held May 23-26, 2022. Fred Colen, Neovasc's President and Chief Executive Officer, will be presenting |
|
| May 16, 2022 |
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of prin |
|
| May 13, 2022 |
Neovasc Announces First Quarter Financial Results and Provides Corporate Update Neovasc Announces First Quarter Financial Results and Provides Corporate Update VANCOUVER and MINNEAPOLIS - ( NewsMediaWire ) - May 12, 2022 - Neovasc Inc. |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of prin |
|
| May 12, 2022 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Chris Clark, the Chief Financial Officer of Neovasc Inc. |
|
| May 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of prin |
|
| May 12, 2022 |
Neovasc Inc. Management?s Discussion and Analysis FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND 2021 (Expressed in U.S. Dollars) Q1 2022 MANAGEMENT'S DISCUSSION AND ANALYSIS This Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") covers the unaudited condensed interim consolidated financial statements of Neovasc Inc. (the "Company", "Neovasc", "we", "us" |
|
| May 12, 2022 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Fred Colen, the President and Chief Executive Officer of Neovasc Inc. |
|
| May 12, 2022 |
See Accompanying Notes to the Condensed Interim Consolidated Financial Statements Neovasc Inc. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND 2021 (Expressed in U.S. dollars) CONTENTS Page Condensed Interim Consolidated Statements of Financial Position 1 Condensed Interim Consolidated Statements of Loss and Comprehensive Loss 2 Condensed Interim Consolidated Statements of Changes in Equity 3 Condensed Interim Consolidated State |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pr |
|
| April 29, 2022 |
Neovasc to Report First Quarter Financial Results on May 12, 2022 Neovasc to Report First Quarter Financial Results on May 12, 2022 VANCOUVER and MINNEAPOLIS, MN via NewMediaWire - Neovasc Inc. |
|
| April 28, 2022 |
NASDAQ, TSX: NVCN Neovasc Comments on European Heart Journal Publication Report demonstrates objective improvements in patients suffering from microvascular dysfunction VANCOUVER and MINNEAPOLIS, April 28, 2022 - Neovasc, Inc. |
|
| April 28, 2022 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Cana |
|
| April 27, 2022 |
Neovasc Announces Effective Date of Share Consolidation EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Announces Effective Date of Share Consolidation VANCOUVER, BC via NewMediaWire - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, and in the development of minimally invasive transcatheter mitral valve replacement technologies, announc |
|
| April 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pr |
|
| April 27, 2022 |
Neovasc Announces Effective Date of Share Consolidation Exhibit 99.1 Neovasc Announces Effective Date of Share Consolidation VANCOUVER, BC ? April 27, 2022 - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, and in the development of minimally invasive transcatheter mitral valve replacement technologies, announced today that the Company |
|
| April 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pr |
|
| April 26, 2022 |
DEL AM 1 tm2213074d3delam.htm DEL AM April 26, 2022 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Re: Neovasc Inc. Registration Statement on Form F-3 File No. 333-264444 Ladies and Gentlemen: Reference is made to the Registration Statement on Form F-3 (File No. 333-264444) filed by Neovasc Inc. on April 22, 2022 (the “Registration Statement”). Pursuant to |
|
| April 22, 2022 |
Exhibit 107 Calculation of Filing Fee Table Form F-3 (Form Type) NEOVASC INC. (Exact Name of Registrant as Specified in its Charter) CALCULATION OF REGISTRATION FEE Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount |
|
| April 22, 2022 |
As filed with the Securities and Exchange Commission on April 22, 2022 Registration No. |
|
| April 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pr |
|
| April 20, 2022 |
Neovasc to Participate in Bloom Burton & Co. Healthcare Investment Conference Neovasc to Participate in Bloom Burton & Co. Healthcare Investment Conference VANCOUVER and MINNEAPOLIS via NewMediaWire - Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the 2022 Bloom Burton & Co. Healthcare Investment Conference to be held May 2-3, 2022. Fred Colen, Neovasc's Chief Executive Officer, will be present |
|
| April 13, 2022 |
NEOVASC INC. REPORTS RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 NEWS RELEASE NASDAQ, TSX: NVCN NEOVASC INC. REPORTS RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS Vancouver, BC, Canada - April 13, 2022 - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General and Special Meeting of Shareholders held on April 12 |
|
| April 13, 2022 |
6-K 1 tm2212350d16k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbi |
|
| April 13, 2022 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Cana |
|
| March 24, 2022 |
RESTATED SECURITIES PURCHASE AGREEMENT STRUL MEDICAL GROUP LLC NEOVASC INC. DATED MARCH 23, 2022 EX-99.1 2 tm2210169d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 RESTATED SECURITIES PURCHASE AGREEMENT BETWEEN STRUL MEDICAL GROUP LLC AND NEOVASC INC. DATED MARCH 23, 2022 TABLE OF CONTENTS PAGE Article 1 DEFINITIONS AND INTERPRETATION 1 Section 1.1 Definitions 1 Section 1.2 Interpretation 7 Section 1.3 Control 8 Section 1.4 Knowledge 9 Section 1.5 Schedules 9 Article 2 Subscription 9 Section 2.1 Resta |
|
| March 24, 2022 |
Neovasc Announces Consolidation and Extension of Convertible Debt Neovasc Announces Consolidation and Extension of Convertible Debt VANCOUVER, BC - via NewMediaWire - Neovasc Inc. |
|
| March 24, 2022 |
6-K 1 tm2210169d16k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant’s name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbi |
|
| March 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pr |
|
| March 10, 2022 |
Exhibit 12.1 Certification of the Chief Executive Officer of Neovasc Inc. Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, As adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 CERTIFICATIONS I, Fred Colen, certify that: 1. I have reviewed this annual report on Form 20-F of Neovasc Inc. (the "Company"); 2. Based on my knowledge, this report does n |
|
| March 10, 2022 |
Exhibit 15.1 Grant Thornton LLP Suite 1600 333 Seymour Street Vancouver, BC V6B 0A4 T +1 604 687 2711 F +1 604 685 6569 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our report dated March 9, 2022, with respect to the consolidated financial statements included in the Annual Report of Neovasc Inc. on Form 20-F for the year ended December 31, 2021. We consent to the incorpo |
|
| March 10, 2022 |
Exhibit 12.2 Certification of the Principal Financial Officer of Neovasc Inc. Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, As adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 CERTIFICATIONS I, Chris Clark, certify that: 1. I have reviewed this annual report on Form 20-F of Neovasc Inc. (the "Company"); 2. Based on my knowledge, this report d |
|
| March 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 10, 2022 |
Neovasc Announces Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update VANCOUVER and MINNEAPOLIS via NEWMEDIAWIRE - March 10, 2022 - Neovasc Inc. |
|
| March 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pr |
|
| March 10, 2022 |
Exhibit 13.1 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the annual report of Neovasc Inc. (the “Registrant”) filed under cover of Form 20-F for the period ended December 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Fred A. Colen as Chief |
|
| February 24, 2022 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, C |
|
| February 24, 2022 |
Neovasc to Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022 EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc to Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022 VANCOUVER - via NewMediaWire - Neovasc Inc. (NASDAQ, TSX: NVCN), will report financial results for the quarter and full year ended December 31, 2021 on Thursday, March 10, 2022. Neovasc's President and Chief Executive Officer Fred Colen, and Chris Clark, Chief Financial Of |
|
| February 14, 2022 |
NVCN / Neovasc, Inc . / CVI Investments, Inc. - SC 13G/A Passive Investment CUSIP No: 64065J304 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2. (Amendment No. 1)* Neovasc Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 64065J304 (CUSIP Number) December 31, 2021 (D |
|
| February 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| February 8, 2022 |
Neovasc Announces German Reimbursement Renewal and Commercial Progress Neovasc Announces German Reimbursement Renewal and Commercial Progress VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc, Inc. |
|
| February 4, 2022 |
Independent Publication Reports Neovasc Reducer™ Demonstrates Cost Savings Independent Publication Reports Neovasc Reducer? Demonstrates Cost Savings VANCOUVER and MINNEAPOLIS NewMediaWire - Neovasc, Inc. |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| February 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| February 2, 2022 |
Neovasc Announces Complete Dismissal of Securities Class Action Complaint with Prejudice EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Announces Complete Dismissal of Securities Class Action Complaint with Prejudice VANCOUVER and MINNEAPOLIS, via NewMediaWire - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), today announced the complete dismissal of the consolidated amended complaint in the shareholder class action case captioned In re Neovasc Inc. Securities Litigatio |
|
| January 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| January 20, 2022 |
Neovasc Announces Publication Supporting the Neovasc Reducer™ Device Neovasc Announces Publication Supporting the Neovasc Reducer? Device VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc, Inc. |
|
| January 18, 2022 |
Neovasc Announces Case Series of First U.S. Reducer Implants Published In Peer-Reviewed Journal EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Announces Case Series of First U.S. Reducer Implants Published In Peer-Reviewed Journal VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced the publication of a case series in the journal Cardiovascular Revascularization Medicine describing successful uses of the Neovasc Reducer™ |
|
| January 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| January 6, 2022 |
Neovasc to Participate in H.C. Wainwright BIOCONNECT Virtual Conference EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc to Participate in H.C. Wainwright BIOCONNECT Virtual Conference VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ,TSX: NVCN) today announced that its management team will be participating in the 2022 H.C. Wainwright BIOCONNECT Virtual Conference to be held January 10-13, 2022. A recorded presentation by |
|
| January 6, 2022 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Ca |
|
| January 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| January 5, 2022 |
COSIRA-II Trial Designed to Study the Neovasc Reducer™ for Patients with Refractory Angina EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Announces First Patient Enrollment in COSIRA-II Trial COSIRA-II Trial Designed to Study the Neovasc Reducer™ for Patients with Refractory Angina VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced enrollment of the first patient in the COSIRA-II clinical trial. COSIRA-II (COronar |
|
| December 1, 2021 |
Neovasc to Participate in Sidoti December Virtual Microcap Conference Neovasc to Participate in Sidoti December Virtual Microcap Conference VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. |
|
| December 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| November 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| November 30, 2021 |
Neovasc Reducer™ System Receives National Reimbursement in France EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Reducer™ System Receives National Reimbursement in France First therapy to receive newly established French reimbursement designation VANCOUVER and MINNEAPOLIS via NewMediaWire - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the Neovasc Reducer™ ("Reducer") system has been granted Prise en Charge Transitoire ("PECT |
|
| November 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| November 24, 2021 |
Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance VANCOUVER and MINNEAPOLIS via NewMediaWire - Neovasc Inc. |
|
| November 24, 2021 |
The National Institute for Health and Care Excellence of The United Kingdom Provides Positive Guidance for Neovasc Reducer System VANCOUVER and MINNEAPOLIS via NewMediaWire - Neovasc Inc. |
|
| November 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| November 9, 2021 |
See Accompanying Notes to the Condensed Interim Consolidated Financial Statements Neovasc Inc. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020 (Expressed in U.S. dollars) CONTENTS Page Condensed Interim Consolidated Statements of Financial Position 1 Condensed Interim Consolidated Statements of Loss and Comprehensive Loss 2 Condensed Interim Consolidated Statements of Changes in Equity 3 Condensed Interim Conso |
|
| November 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| November 9, 2021 |
Neovasc Announces Third Quarter 2021 Financial Results and Provides Corporate Update NASDAQ, TSX: NVCN Neovasc Announces Third Quarter 2021 Financial Results and Provides Corporate Update VANCOUVER and MINNEAPOLIS via NewMediaWire - Neovasc, Inc. |
|
| November 9, 2021 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, C |
|
| November 9, 2021 |
Neovasc Inc. Management?s Discussion and Analysis FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020 (Expressed in U.S. dollars) Q3 2021 MANAGEMENT'S DISCUSSION AND ANALYSIS This Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") covers the unaudited condensed interim consolidated financial statements of Neovasc Inc. (the "Company", "Neovasc |
|
| November 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| November 1, 2021 |
Neovasc to Report Third Quarter 2021 Financial Results on November 9, 2021 Neovasc to Report Third Quarter 2021 Financial Results on November 9, 2021 VANCOUVER - via NewMediaWire - Neovasc Inc. |
|
| October 21, 2021 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Ca |
|
| October 21, 2021 |
Publication Highlights Device Success in Chronic Total Occlusions of the Right Coronary Artery Neovasc Reducer? Featured in Polish Heart Journal Publication Highlights Device Success in Chronic Total Occlusions of the Right Coronary Artery VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. |
|
| September 28, 2021 |
Neovasc REDUCER-I Study Published in EuroIntervention Journal Neovasc REDUCER-I Study Published in EuroIntervention Journal VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. |
|
| September 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address o |
|
| September 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address o |
|
| September 23, 2021 |
Neovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ,TSX: NVCN) today announced that its management team will be participating in the 2021 Benzinga Healthcare Small Cap Conference to be held September 29-30, 2021. Bill Little, Neovasc's Chief O |
|
| September 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address o |
|
| September 16, 2021 |
Neovasc Announces FDA Approval of COSIRA-II Clinical Trial EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Announces FDA Approval of COSIRA-II Clinical Trial Company on Schedule to Commence Trial Late This Year VANCOUVER and MINNEAPOLIS via NewMediaWire - Neovasc Inc. ("Neovasc" or the "Company") (Nasdaq, TSX: NVCN) announced today that it has received FDA approval for the Investigational Device Exemption ("IDE") regarding the COSIRA-II IDE Clinical Trial. |
|
| August 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of p |
|
| August 30, 2021 |
Neovasc to Participate in H.C. Wainwright & Co. 23rd Annual Global Investment Conference Neovasc to Participate in H.C. Wainwright & Co. 23rd Annual Global Investment Conference VANCOUVER and MINNEAPOLIS - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ,TSX: NVCN) today announced that its management team will be participating in the 23rd Annual H.C. Wainwright Global Investment Conference to be held September 13-15, 2021. A pre-recorded company presentation will be available beginn |
|
| August 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of p |
|
| August 17, 2021 |
Neovasc Announces Submission of COSIRA-II Protocol Supplement to FDA Neovasc Announces Submission of COSIRA-II Protocol Supplement to FDA VANCOUVER and MINNEAPOLIS via NewMediaWire - Neovasc Inc. |
|
| August 16, 2021 |
Neovasc Inc. Management?s Discussion and Analysis FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2021 AND 2020 (Expressed in U.S. Dollars) Q2 2021 MANAGEMENT'S DISCUSSION AND ANALYSIS This Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") covers the unaudited condensed interim consolidated financial statements of Neovasc Inc. (the "Company", "Neovasc", "we |
|
| August 16, 2021 |
Form 52-109F2 Certification of Interim Filings Full Certificate EX-99.3 4 exhibit99-3.htm EXHIBIT 99.3 Form 52-109F2 Certification of Interim Filings Full Certificate I, Fred Colen, the President and Chief Executive Officer of Neovasc Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Neovasc Inc. (the "issuer") for the interim period ended June 30, 2021. 2. No misrepresent |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of p |
|
| August 16, 2021 |
Neovasc Announces Second Quarter 2021 Financial Results Neovasc Announces Second Quarter 2021 Financial Results VANCOUVER and MINNEAPOLIS - Neovasc, Inc. |
|
| August 16, 2021 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Chris Clark, the Chief Financial Officer of Neovasc Inc. |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of p |
|
| August 16, 2021 |
See Accompanying Notes to the Condensed Interim Consolidated Financial Statements EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Inc. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2021 AND 2020 (Expressed in U.S. dollars) CONTENTS Page Condensed Interim Consolidated Statements of Financial Position 1 Condensed Interim Consolidated Statements of Loss and Comprehensive Loss 2 Condensed Interim Consolidated Statements of Changes in |
|
| July 27, 2021 |
Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021 Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021 VANCOUVER via NewMediaWire - Neovasc Inc. |
|
| July 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pri |
|
| July 13, 2021 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canad |
|
| July 13, 2021 |
Neovasc Announces New Appointments in Regulatory and Clinical Leadership Neovasc Team Grows with Addition of Industry Veterans Lisa Becker as VP, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as VP of Clinical Affairs VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. |
|
| June 21, 2021 |
Largest Real-World Registry Supporting Neovasc Reducer? Safety and Efficacy Outcomes Published in International Journal of Cardiology VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. |
|
| June 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pri |
|
| June 10, 2021 |
Neovasc Provides Corporate Update Neovasc Provides Corporate Update VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. |
|
| June 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pri |
|
| June 7, 2021 |
Neovasc Reducer System Receives First National Reimbursement in Europe NHS England Provides National Coverage VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. |
|
| June 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pri |
|
| June 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pri |
|
| June 4, 2021 |
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders Vancouver, BC, Canada - via NewMediaWire - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on June 3, 2021 in Vancouver, B.C. (the "Meeting"). At the Meeting, the shareholders of the Company (th |
|
| May 26, 2021 |
Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced today that it has received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compli |
|
| May 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of prin |
|
| May 20, 2021 |
Neovasc Provides Update on German Litigation Neovasc Provides Update on German Litigation VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. |
|
| May 20, 2021 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada |
|
| May 13, 2021 |
Neovasc to Sponsor Symposium on Reducer at EuroPCR Neovasc to Sponsor Symposium on Reducer at EuroPCR VANCOUVER and MINNEAPOLIS - May 13, 2021 - Neovasc Inc. |
|
| May 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of prin |
|
| May 10, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of prin |
|
| May 10, 2021 |
Neovasc Announces First Patient Enrollment in COSIMA Trial Neovasc Announces First Patient Enrollment in COSIMA Trial VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc Inc. |
|
| May 6, 2021 |
Neovasc Announces First Quarter 2021 Financial Results Neovasc Announces First Quarter 2021 Financial Results VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc, Inc. |
|
| May 6, 2021 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Chris Clark, Chief Financial Officer of Neovasc Inc. |
|
| May 6, 2021 |
MANAGEMENT'S DISCUSSION AND ANALYSIS This Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") covers the unaudited condensed interim consolidated financial statements of Neovasc Inc. |
|
| May 6, 2021 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Fred Colen, Chief Executive Officer of Neovasc Inc. |
|
| May 6, 2021 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada |
|
| May 6, 2021 |
See Accompanying Notes to the Condensed Interim Consolidated Financial Statements Neovasc Inc. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2021 AND 2020 (Expressed in U.S. dollars) CONTENTS Page Condensed Interim Consolidated Statements of Financial Position 1 Condensed Interim Consolidated Statements of Loss and Comprehensive Loss 2 Condensed Interim Consolidated Statements of Changes in Equity 3 Condensed Interim Consolidated State |
|
| May 6, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of prin |
|
| May 4, 2021 |
FORM 51-102F3 MATERIAL CHANGE REPORT Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company Neovasc Inc. (?Neovasc? or the ?Company?) 13562 Maycrest Way, Suite 5138 Richmond, BC V6V 2J7 Item 2: Date of Material Change January 15, 2021 Item 3: News Release A news release announcing the material change was issued on January 15, 2021 through Newsfile Corp. and a copy was subsequently filed on SEDAR and EDG |
|
| May 4, 2021 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 tm2113192d46k.htm FORM 6-K Securities and Exchange Commission washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2021 Commission File Number 001-36458 Neovasc Inc. (Translation of registrant’s name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J |
|
| May 4, 2021 |
F-10/A 1 tm2113192d3f10a.htm F-10/A As filed with the Securities and Exchange Commission on May 3, 2021 Registration No. 333-255293 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM F-10 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NEOVASC INC. (Exact name of Registrant as specified in its charter) Canada 3841 Not Applicable (State or other |
|
| April 28, 2021 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Cana |
|
| April 28, 2021 |
Neovasc Provides Reducer Reimbursement Progress Update EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Provides Reducer Reimbursement Progress Update VANCOUVER and MINNEAPOLIS, via NewMediaWire - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced progress towards its value creation strategy of expanding global reimbursement for the Neovasc Reducer™ ("Reducer"). Expanding reimbursement for the Reducer is a key component of Neo |
|
| April 27, 2021 |
Neovasc to Report First Quarter 2021 Financial Results on May 6, 2021 Neovasc to Report First Quarter 2021 Financial Results on May 6, 2021 VANCOUVER and MINNEAPOLIS, via NewMediaWire - Neovasc Inc. |
|
| April 27, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pr |
|
| April 19, 2021 |
Neovasc Comments on EuroIntervention Article Neovasc Comments on EuroIntervention Article VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc, Inc. |
|
| April 19, 2021 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Cana |
|
| April 16, 2021 |
F-10 1 tm2113192d1f10.htm F-10 As filed with the Securities and Exchange Commission on April 16, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-10 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NEOVASC INC. (Exact name of Registrant as specified in its charter) Canada 3841 Not Applicable (State or other Jurisdiction (Primary Stand |
|
| April 16, 2021 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Cana |
|
| April 16, 2021 |
F-X 1 tm2113192d2fx.htm F-X UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing (“Filer”): NEOVASC INC. B. (1) This is an (check one): x original filing for the Filer. ¨ amended filing for the Filer. (2) Check the following box if you are filing the Form F-X in paper in accor |
|
| April 16, 2021 |
Neovasc Provides Tiara TA Update Neovasc Provides Tiara TA Update VANCOUVER and MINNEAPOLIS, via NewMediaWire - Neovasc Inc. |
|
| March 11, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pr |
|
| March 11, 2021 |
Audited Consolidated Financial Statements for the year ended December 31, 2020 TABLE OF CONTENTS Exhibit 99.3? Neovasc Inc. CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2020, 2019 and 2018 ? (Expressed in U.S. dollars) TABLE OF CONTENTS? CONTENTS ? ? ? Page ? Report of Independent Registered Public Accounting Firm ? ? 1???2 ? Consolidated Statements of Financial Position ? ? 3 ? Consolidated Statements of Loss and Comprehensive Loss ? ? 4 ? Consolidated |
|
| March 11, 2021 |
Management’s Discussion & Analysis for the year ended December 31, 2020 EX-99.2 3 tm2039647d1ex99-2.htm EX-99.2 Exhibit 99.2 Neovasc Inc. Management’s Discussion and Analysis FOR THE YEARS ENDED DECEMBER 31 2020, 2019 AND 2018 (Expressed in U.S. Dollars) Q4 2020 MANAGEMENT’S DISCUSSION AND ANALYSIS This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) covers the audited consolidated financial statements of Neovasc Inc. (th |
|
| March 11, 2021 |
Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc, Inc. |
|
| March 11, 2021 |
? Exhibit 99.5? Certification of the Principal Financial Officer of Neovasc Inc. Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 CERTIFICATIONS I, Chris Clark, certify that: 1. I have reviewed this annual report on Form 40-F of Neovasc Inc. (the ?Company?); ? 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact ne |
|
| March 11, 2021 |
? Exhibit 99.7? CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our report dated March 10, 2021, with respect to the consolidated financial statements included in the Annual Report of Neovasc Inc. on Form 40-F for the year ended December 31, 2020. We consent to the inclusion of said report in the Annual Report of Neovasc Inc. on Form 40-F and to the incorporation by referen |
|
| March 11, 2021 |
? Exhibit 99.4? Certification of the Chief Executive Officer of Neovasc Inc. Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 CERTIFICATIONS I, Fred Colen, certify that: 1. I have reviewed this annual report on Form 40-F of Neovasc Inc. (the ?Company?); ? 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessa |
|
| March 11, 2021 |
? Exhibit 99.6? CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the annual report of Neovasc Inc. (the ?Registrant?) filed under cover of Form 40-F for the period ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), Fred A. Colen as Chief Executive Officer of the Registrant and Chr |
|
| March 11, 2021 |
40-F 1 tm2039647-140f.htm 40-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 or ☒ ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Commission File Number: 001-36458 Neovasc Inc. (Exact name of R |
|
| March 11, 2021 |
Annual Information Form for the year ended December 31, 2020 TABLE OF CONTENTS Exhibit 99.1? NEOVASC INC. ? ANNUAL INFORMATION FORM ? FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020 ? ? ? March 11, 2021 TABLE OF CONTENTS? ? GLOSSARY ? ? ? ? 2 ? ? ? TERMS OF REFERENCE ? ? ? ? 3 ? ? ? CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND RISK FACTORS ? ? ? ? 4 ? ? ? CORPORATE STRUCTURE ? ? ? ? 8 ? ? ? Intercorporate Relationships ? ? ? ? 8 ? ? ? GENERAL DEVELO |
|
| March 4, 2021 |
Neovasc to Report Fourth Quarter and Fiscal Year 2020 Results on March 11, 2021 Neovasc to Report Fourth Quarter and Fiscal Year 2020 Results on March 11, 2021 VANCOUVER and MINNEAPOLIS - via NewMediaWire - Neovasc, Inc. |
|
| March 4, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pr |
|
| March 3, 2021 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Cana |
|
| March 3, 2021 |
Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference VANCOUVER and MINNEAPOLIS, via NewMediaWire - Neovasc Inc. (NASDAQ, TSX: NVCN), today announced that company management will be participating in the 2021 H.C. Wainwright Global Life Sciences Conference that is scheduled to take place March 9-10, 2021. A recorded presentation by Bill Little, Neovasc's Chief Operating Off |
|
| March 2, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of pr |
|
| March 2, 2021 |
Neovasc Comments on Clinical Cardiology Journal Publication Neovasc Comments on Clinical Cardiology Journal Publication VANCOUVER and MINNEAPOLIS, via NewMediaWire - Neovasc, Inc. |
|
| February 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 NEOVASC INC (Name of Issuer) Common Shares (Title of Class of Securities) 64065J304 (CUSIP Number) FiveT Investment Management Ltd c/o DMS Corporate Services, Suite 5B201, 2nd Floor, One Nexus Way Camana Bay, Grand Cayman, Cayman Islands KY1-1108 +1 345 749 2552 (Name, Add |
|
| February 24, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| February 24, 2021 |
Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule VANCOUVER and MINNEAPOLIS, via NewMediaWire - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), has received written notification (the "Nasdaq Notice") from the Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with the minimum market value req |
|
| February 23, 2021 |
Current Report of Foreign Issuer - FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February 2021 Commission file Number 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 -13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of principal execu |
|
| February 23, 2021 |
COMMON SHARE PURCHASE WARRANT NEOVASC INC. Exhibit 99.3 COMMON SHARE PURCHASE WARRANT NEOVASC INC. Warrant Shares: [?] Initial Exercise Date: February [?], 2021 THIS COMMON SHARE PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, [?] or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the ?In |
|
| February 23, 2021 |
PLACEMENT AGENT COMMON SHARE PURCHASE WARRANT NEOVASC INC. Exhbit 99.4 PLACEMENT AGENT COMMON SHARE PURCHASE WARRANT NEOVASC INC. Warrant Shares: [?] Initial Exercise Date: February [?], 2021 THIS COMMON SHARE PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, [?] or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date |
|
| February 23, 2021 |
FORM 51-102F3 MATERIAL CHANGE REPORT EX-99.1 2 tm217545d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company Neovasc Inc. (“Neovasc” or the “Company”) 13562 Maycrest Way, Suite 5138 Richmond, BC V6V 2J7 Item 2: Date of Material Change February 12, 2021 Item 3: News Release A news release announcing the material change was issued on February 12, 2021 through Newsfile Corp. and |
|
| February 23, 2021 |
Exhibit 99.2 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of February 10, 2021, between Neovasc Inc., a corporation organized and existing under the laws of Canada (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively the ?Purchasers?). WHEREAS, subj |
|
| February 19, 2021 |
CUSIP No: 64065J304 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2. (Amendment No. )* Neovasc Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 64065J304 (CUSIP Number) February 10, 2021 (Da |
|
| February 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Neovasc Inc. (Name of Issuer) Common shares, no par value per share (Title of Class of Securities) 64065J304 (CUSIP Number) February 10, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| February 17, 2021 |
EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc to Participate in 10th Annual SVB Leerink Global Healthcare Conference VANCOUVER, via NewMediaWire - Neovasc Inc. (NASDAQ, TSX: NVCN), today announced that company management will be participating in the 10th Annual SVB Leerink Global Healthcare Conference that is scheduled to take place from February 24 to 26, 2021. Fred Colen, Neovasc's President an |
|
| February 17, 2021 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, C |
|
| February 12, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, Canada, V6V 2J7 (Address of |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* NEOVASC INC. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 64065J304 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| February 12, 2021 |
NEOVASC ANNOUNCES CLOSING OF US$72 MILLION REGISTERED DIRECT OFFERING OF COMMON SHARES PRICED AT-THE-MARKET VANCOUVER, CANADA - Neovasc Inc. |
|
| February 11, 2021 |
SUPPL 1 tm215359d2suppl.htm SUPPL Filed Pursuant to General Instruction II.L of Form F-10 File No. 333-251330 PROSPECTUS SUPPLEMENT To Short Form Base Shelf Prospectus dated August 12, 2020 as Amended December 14, 2020 New Issue February 10, 2021 NEOVASC INC. US$72,000,000.00 Units Consisting of (I) One Common Share, and (II) One-half of One Common Share Purchase Warrant US$2.00 per Unit This pros |
|
| February 10, 2021 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, C |
|
| February 10, 2021 |
Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market Vancouver, Canada via NewMediaWire - Neovasc Inc. |
|
| February 9, 2021 |
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule VANCOUVER and MINNEAPOLIS, via NewMediaWire - Neovasc, Inc. |
|
| February 9, 2021 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, C |
|
| February 5, 2021 |
Current Report of Foreign Issuer - FORM 6-K 6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2021 Commission File Number: 001-36458 Neovasc Inc. (Translation of registrant's name into English) Suite 5138 - 13562 Maycrest Way Richmond, British Columbia, C |
|
| February 5, 2021 |
Neovasc Comments on Journal of the American Heart Association Publication EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Neovasc Comments on Journal of the American Heart Association Publication VANCOUVER and MINNEAPOLIS, via NewMediaWire - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the Journal of the American Heart Association has published an article entitled, "Angina Severity, Mortality, and Healthcare Utilization Among Veterans with |
|
| February 4, 2021 |
SUPPL 1 tm215359-1suppl.htm SUPPL Filed Pursuant to General Instruction II.L of Form F-10 File No. 333-251330 PROSPECTUS SUPPLEMENT To Short Form Base Shelf Prospectus dated August 12, 2020 as Amended December 14, 2020 New Issue February 4, 2021 NEOVASC INC. 6,230,803 Common Shares This prospectus supplement of Neovasc Inc. (“Neovasc”, the “Company” or “We”) relates to the issuance, from time to t |
